ESCRS - International Niemann-Pick Disease Alliance (INPDA) launches awareness campaign

International Niemann-Pick Disease Alliance (INPDA) launches awareness campaign

International Niemann-Pick Disease Alliance (INPDA) launches awareness campaign

Think NP-C is a global campaign targeting healthcare professionals that may see symptoms of this rare disease including ophthalmologists who may notice vertical supranuclear gaze palsy which is one of the many symptoms.

NP-C is commonly undetected or misdiagnosed.  This is often due to its highly variable clinical presentation characterised by a wide range of symptoms that individually are not specific to the disease1,4 Symptoms can be categorised as visceral (including hepatosplenomegaly), neurological (including vertical supranuclear gaze palsy, ataxia and developmental delay) or psychiatric (including early onset psychosis and prominent visual hallucinations).

 www.think-npc.com.

 

Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...